Apply Give

Other ways to search: Events Calendar | UTHSC

Dr Colin Howden on the Recent FDA Approval of Vonoprazan

Written by Communications and Marketing

|

Following the recent FDA approval for vonoprazan (Voquenza) in the treatment of gastroesophageal reflux disease, Colin Howden, MD, professor of medicine at the University of Tennessee Health Science Center, joined for an interview to discuss the inner workings of the drug, patient monitoring, and potential future uses.

Top Publishers